SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4601seeking alpha...pretty much on point imo.. Future of Genzyme / Isis Pharma'bob zagorin-9/3/2010
4600i added on latest results and conf. call..isis is a compelling value here. the lbob zagorin-9/2/2010
4599Bob Like you I keep an eye on Isis. Their patents are numerous. I also check MJ-9/2/2010
4598deleted, see next postMJ-9/2/2010
4597Genzyme says drug lowers cholesterol By Globe Staff | September 2, 2010 Genzbob zagorin-9/2/2010
4596Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC Press Releabob zagorin-9/1/2010
4595Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discusbob zagorin-8/30/2010
4594Regulus Therapeutics Announces U.S. Allowance of a Key Tuschl III Patent Coverinbob zagorin-8/10/2010
4593Q results: finance.yahoo.combob zagorin-8/9/2010
4592report from HEART-wire Mipomersen passes hurdle in two trials August 5, 2010 | Mbob zagorin-8/9/2010
4591anyone care to comment on this thesis.. blinded study. patients don't know bob zagorin-8/4/2010
4590Tuesday 3 August 2010, 16:06 GMT (12:06pm EST) * Sanofi bid marks bold move intbob zagorin-8/4/2010
4589For the general population of hypercholesterolemia patients on statins, incidenctuck-8/4/2010
4588The dropouts were due to unexplained - so far as I could tell - "adverse evtom pope-8/4/2010
4587Does anyone know the incidence of enzyme elevation with statins, both among thebiofisher-8/4/2010
4586I think you've got the general idea right, despite any scrambling of the distuck-8/4/2010
4585Feuerstein's take. Impressive results, but for one little thing that might wtom pope-8/4/2010
4584I got the name of the disease wrong. ... The companies said the initial filingIan@SI-8/4/2010
4583I heard the CEO being interviewed on CNBC. He believes the problem is manageablIan@SI-8/4/2010
4582"Elevations in liver enzymes in patients treated with mipomersen, a possiblscots40-8/4/2010
4581Vical to Present at Canaccord Genuity Growth Conference Press Release Source: Vbob zagorin-8/4/2010
4580Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results onbob zagorin-8/4/2010
4579UPDATE 2-Isis-Genzyme cholesterol drug meets study goals Wednesday 4 August 201bob zagorin-8/4/2010
4578I doubt that Excaliard is worth following for an IPO but I could be wrong. I doIan@SI-8/3/2010
4577Isis Earns $5 Million Milestone Payment From GSK for Designation of a Developmenbob zagorin-7/29/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News